Display options
Cite
Zeng K, Zhong B, Shen XL, et al. RNAi targeting Nogo Receptor enhanced survival and proliferation of murine retinal ganglion cells during N-methyl-D-aspartate-induced optic nerve crush. Oncotarget. 2017;8(39):65009-65021doi: 10.18632/oncotarget.17351.
Zeng, K., Zhong, B., Shen, X. L., Fang, M., Lin, B. T., & Ma, D. H. (2017). RNAi targeting Nogo Receptor enhanced survival and proliferation of murine retinal ganglion cells during N-methyl-D-aspartate-induced optic nerve crush. Oncotarget, 8(39), 65009-65021. https://doi.org/10.18632/oncotarget.17351
Zeng, Kun, et al. "RNAi targeting Nogo Receptor enhanced survival and proliferation of murine retinal ganglion cells during N-methyl-D-aspartate-induced optic nerve crush." Oncotarget vol. 8,39 (2017): 65009-65021. doi: https://doi.org/10.18632/oncotarget.17351
Zeng K, Zhong B, Shen XL, Fang M, Lin BT, Ma DH. RNAi targeting Nogo Receptor enhanced survival and proliferation of murine retinal ganglion cells during N-methyl-D-aspartate-induced optic nerve crush. Oncotarget. 2017 Apr 21;8(39):65009-65021. doi: 10.18632/oncotarget.17351. eCollection 2017 Sep 12. PMID: 29029408; PMCID: PMC5630308.
Copy Download .nbib Format: NLM
Share it on

Oncotarget. 2017 Apr 21;8(39):65009-65021. doi: 10.18632/oncotarget.17351. eCollection 2017 Sep 12.

RNAi targeting Nogo Receptor enhanced survival and proliferation of murine retinal ganglion cells during N-methyl-D-aspartate-induced optic nerve crush.

Oncotarget

Kun Zeng, Bo Zhong, Xiao-Li Shen, Min Fang, Bao-Tao Lin, Da-Hui Ma

Affiliations

  1. Key Laboratory of Ophthalmology, Shenzhen Eye Hospital, Ophthalmology College of Shenzhen University, Shenzhen 518000, P.R. China.
  2. Department of Stomatology, Shenzhen Second People's Hospital, Shenzhen 518000, P.R. China.

PMID: 29029408 PMCID: PMC5630308 DOI: 10.18632/oncotarget.17351

Abstract

We investigated the effects of lentivirus-mediated RNAi targeting of Nogo Receptor (

Keywords: Nogo receptor; RNA interference; apoptosis; mouse retinal ganglion cells; proliferation

Conflict of interest statement

CONFLICTS OF INTEREST The authors declare no conflicts of interest.

References

  1. Mol Vis. 2013 Jul 25;19:1667-76 - PubMed
  2. J Biol Chem. 2007 Aug 24;282(34):25088-99 - PubMed
  3. Exp Eye Res. 2009 Oct;89(4):581-9 - PubMed
  4. Proc Natl Acad Sci U S A. 2004 Sep 7;101(36):13352-6 - PubMed
  5. PLoS One. 2014 Sep 03;9(9):e106378 - PubMed
  6. Invest Ophthalmol Vis Sci. 2016 Jan 1;57(1):81-93 - PubMed
  7. Curr Eye Res. 2007 Oct;32(10 ):851-61 - PubMed
  8. Neurosci Lett. 2006 Nov 6;408(1):62-7 - PubMed
  9. Invest Ophthalmol Vis Sci. 2008 Dec;49(12):5546-52 - PubMed
  10. Neurosci Lett. 2009 Sep 4;460(3):223-6 - PubMed
  11. Nature. 2000 Jan 27;403(6768):434-9 - PubMed
  12. Neurochem Int. 2013 Sep;63(3):195-200 - PubMed
  13. Invest Ophthalmol Vis Sci. 2010 Aug;51(8):4084-95 - PubMed
  14. Neural Regen Res. 2014 Apr 15;9(8):815-20 - PubMed
  15. J Cell Mol Med. 2008 Aug;12 (4):1199-204 - PubMed
  16. J Neurosci. 2008 Jan 9;28(2):548-61 - PubMed
  17. Exp Eye Res. 2009 Nov;89(5):665-77 - PubMed
  18. Nature. 2008 Oct 23;455(7216):1076-81 - PubMed
  19. Brain Res. 2006 Jan 27;1070(1):24-30 - PubMed
  20. Invest Ophthalmol Vis Sci. 2008 Jun;49(6):2456-63 - PubMed
  21. J Ethnopharmacol. 2016 Aug 22;190:301-12 - PubMed
  22. J Biol Chem. 2011 May 20;286(20):18026-36 - PubMed
  23. Oncogene. 2008 Oct 27;27(50):6398-406 - PubMed
  24. J Ethnopharmacol. 2016 Dec 24;194:1032-1042 - PubMed
  25. Mol Vis. 2006 Dec 22;12:1660-73 - PubMed
  26. BMC Bioinformatics. 2014 Jun 05;15:169 - PubMed
  27. J Neurosci. 2004 Feb 18;24(7):1646-51 - PubMed
  28. J Cell Sci. 2009 Feb 15;122(Pt 4):437-41 - PubMed
  29. Neuron. 2012 Feb 9;73(3):445-52 - PubMed
  30. Cell Tissue Res. 2003 Mar;311(3):333-42 - PubMed
  31. J Immunol. 2008 Jun 15;180(12):8461-9 - PubMed
  32. Neurobiol Dis. 2008 Dec;32(3):535-42 - PubMed

Publication Types